Octreotide Completed Phase 3 Trials for Hypoglycemia / Diabetes Mellitus Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00804297Octreotide for the Treatment of Sulfonylurea-Associated Hypoglycemia